1/2 CCNY-MSK Partnership for Cancer Research, Education and Community Outreach
- Institution
- CITY COLLEGE OF NEW YORK, NY
- Principal investigator
- Bao Q Vuong
- Funding
- $1.3M
- Duration
- 2008–2029
Moonbase score
Still being scored
Abstract
The CCNY-MSKCC Partnership has successfully created a mutually beneficial, cross-institutional collaboration that has emphasized research across the translational T0-T4 continuum, the creation of an education pipeline for attracting students to careers in cancer research, and the establishment of community networks and resources for conducting community engaged outreach and research for the next five years. The Partnership focus will be Translational Cancer Research. Consistent with this emphasis, our research projects will focus on: 1) understanding the biological and social factors associated with immune checkpoint inhibitors and evaluating an intervention designed to reduce side effect severity and improve treatment attendance; 2) an examination of small molecule regulation of cancer-driving transcription factors using a interdisciplinary strategy of protein chemistry, chemical, and cellular approaches that could lead to targeted treatments relevant to cancers; 3) the impact of AI integrated, UN-style medical interpreting engineering solutions on cancer care; 4) identification of germline and other factors influencing the tumor genome of lung cancers.
Research team
- Tim Alan AhlesPI
- Adriana EspinosaPI
- Francesca M GanyPI
- Bao Q VuongPI
LOADING MOONBASE SCORE
Questions for CITY COLLEGE OF NEW YORK
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · City College of New YorkNot yet scored
Project 2: I CARE (Immunotherapy Cutaneous Adverse events REsearch)
Bao Q Vuong · $196K · 2008–2029
- NIH · Sloan-Kettering Inst Can ResearchNot yet scored
2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach
Adriana Espinosa · $1.5M · 2008–2029
- NIH · City College of New York31
Renewed bone remodeling after pausing long-term bisphosphonate use: Does it replace regions of impaired bone quality and restore mechanical integrity?
Mitchell B Schaffler · $492K · 2023–2029